GammaDelta Therapeutics acquires Lymphact to advance their gamma delta (γδ) T-Cell platform into the clinic
Cantanhede, Portugal, 5 June 2018 - Lymphact – Lymphocyte Activation [...]
GammaDelta featured in The Endpoints 11
This article is by john carroll — originally posted on January 10, 2018 08:48 AM [...]
GammaDelta Therapeutics named as one of the top European biotech companies to watch in 2018
"GammaDelta Therapeutics is taking a whole new approach to T cells by [...]
GammaDelta Therapeutics Q&A Session with Raj Mehta
With the announcement that GammaDelta and Japanese biotechnology giant, Takeda [...]
GammaDelta Therapeutics highlighted in press release by the Treasury announcing new investment into the UK life science sector
GammaDelta Therapeutics highlighted in press release by the Treasury announcing [...]
GammaDelta Therapeutics highlighted in CNBC Europe News
CNBC Europe highlighted GammaDelta Therapeutics in a recent report based [...]
Betting big on Gamma Delta T Cells
Gamma Delta T Cells live in our tissue and form [...]
This Italian Academic-turned-CEO also Launched 7 Cancer Drugs at GSK
This post, by Evelyn Warner has been reposted here from [...]
GammaDelta’s Scientific Co-Founder Adrian Hayday Receives Inaugural Business of Science Leadership Award
London, UK, 19 May 2017 – GammaDelta Therapeutics, an emerging [...]
Takeda and GammaDelta Therapeutics Announce Collaboration to Advance Tissue-derived gamma delta (γδ) T Cells
Osaka, Japan and London, UK - 9 May 2017 - [...]